Measures of Hip Function and Symptoms

Weick, Jack W.; Bullard, Jace; Green, Jordan H.; Gagnier, Joel

doi:10.1002/acr.24231

Cited by 10 publications

(6 citation statements)

References 147 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The gait of the children was observed, and physical examination was performed. We also evaluated the weight‐bearing joint function based on Constant–Murley functional assessment of the shoulder, 10 Mayo clinic performance index for the elbow, 11 Cooney wrist score, 12 Harris hip score, 13 Lysholm knee function scoring scale, 14 and the American Orthopaedic Foot and Ankle Society (AOFAS) ankle‐hindfoot scale 15 . The anteroposterior and lateral X‐ray of both knees were obtained to assess joint abnormality.…”

Section: Methodsmentioning

confidence: 99%

Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia

Yang

Liu

et al. 2023

Pediatric Pulmonology

View full text Add to dashboard Cite

Background With the increase in macrolide‐resistant M. pneumoniae infections, off‐label use is difficult to avoid. This study assessed the safety of moxifloxacin in pediatric patients with severe refractory M. pneumoniae pneumonia (SRMPP). Methods We retrospectively reviewed the medical records of children with SRMPP between January 2017 and November 2020 at Beijing Children's Hospital. They were divided into the moxifloxacin group and azithromycin group according to whether or not moxifloxacin was used. The clinical symptoms, radiographs of both knees, and cardiac ultrasounds of the children were collected after drug withdrawal for at least 1 year. A multidisciplinary team reviewed all adverse events and determined their relationship with moxifloxacin. Results A total of 52 children with SRMPP were included in this study (31 in the moxifloxacin group and 21 in the azithromycin group). In the moxifloxacin group, four patients had arthralgia, one had joint effusion, and seven had heart valve regurgitation. In the azithromycin group, three patients had arthralgia, one had claudication, and one had heart valve regurgitation; no obvious knee abnormalities were observed in the radiographs. No statistically significant differences in clinical symptoms or imaging findings were found between the groups. As for the adverse events, 11 patients in moxifloxacin group were deemed to be doubtfully related and one possibly related to moxifloxacin; in the azithromycin group, four patients were regarded to be doubtfully related to azithromycin and one not related. Conclusion Moxifloxacin was well tolerated and safe for treating SRMPP in children.

show abstract

Section: Methodsmentioning

confidence: 99%

Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia

Yang

Liu

et al. 2023

Pediatric Pulmonology

View full text Add to dashboard Cite

show abstract

“…Joint-related disability was measured using the Hip disability and Osteoarthritis Outcome Score (HOOS) and Knee injury and Osteoarthritis Outcome score (KOOS) ( www.koos.nu ). Normalised scores ranging from 0 (extreme disability) to 100 (no disability) were calculated according to scoring instructions ( www.koos.nu ), and a change of 10 points was considered a meaningful change [ 39 – 41 ].…”

Section: Methodsmentioning

confidence: 99%

The AktiWeb study: feasibility of a web-based exercise program delivered by a patient organisation to patients with hip and/or knee osteoarthritis

Joseph

Dagfinrud

Hagen

et al. 2022

Pilot Feasibility Stud

View full text Add to dashboard Cite

Background Patient organisations may be an under-utilised resource in follow-up of patients requiring long-term exercise as part of their disease management. The purpose of this study was to explore the feasibility of a web-based exercise program delivered by a patient organisation to patients with hip and/or knee osteoarthritis (OA). Methods In this pre–post feasibility study, patients aged 40–80 years with hip and/or knee OA were recruited from Diakonhjemmet Hospital. The 12-week intervention was delivered through a patient organisation’s digital platform. Feasibility was evaluated by proportion of eligible patients enrolled, proportion of enrolled patients who provided valid accelerometer data at baseline, and proportion completing the cardiorespiratory exercise test according to protocol at baseline and completed follow-up assessments. Patient acceptability was evaluated for website usability, satisfaction with the initial exercise level and comprehensibility of the exercise program. Change in clinical outcomes were assessed for physical activity, cardiorespiratory fitness and patient-reported variables. Results In total, 49 eligible patients were identified and 35 were enrolled. Thirty (86%) of these attended baseline assessments and provided valid accelerometer data and 18 (51%) completed the maximal cardiorespiratory exercise test according to protocol. Twenty-two (63%) patients completed the follow-up questionnaire, and they rated the website usability as ‘acceptable’ [median 77.5 out of 100 (IQR 56.9, 85.6)], 19 (86%) reported that the initial exercise level was ‘just right’ and 18 (82%) that the exercise program was ‘very easy’ or ’quite easy’ to comprehend. Improvement in both moderate to vigorous physical activity (mean change 16.4 min/day; 95% CI 6.9 to 25.9) and cardiorespiratory fitness, VO2peak (mean change 1.83 ml/kg/min; 95% CI 0.29 to 3.36) were found in a subgroup of 8 patients completing these tests. Across all patient-reported outcomes 24–52% of the patients had a meaningful improvement (n = 22). Conclusion A web-based exercise program delivered by a patient organisation was found to be feasible and acceptable in patients with hip and/or knee OA. Trial registration ClinicalTrials.gov, NCT04084834 (registered 10 September 2019). The Regional Committee for Medical and Health Research Ethics south-east, 2018/2198. URL: Prosjekt #632074 - Aktiv med web-basert støtte. - Cristin (registered 7 June 2019).

show abstract

“…A total score of <70 is considered a poor result, 70–80 fair, 80–90 good, and 90–100 excellent. 20 In this study, we classified patients into HHS score ≥90 (patients with excellent prognosis) and <90 points (patients with referred to poor prognosis). 21…”

Section: Methodsmentioning

confidence: 99%

Prediction Models for Prognosis of Femoral Neck–Fracture Patients 6 Months after Total Hip Arthroplasty

Zheng¹,

Xiao²,

Xie³

et al. 2022

IJGM

View full text Add to dashboard Cite

Purpose To establish prediction models for 6-month prognosis in femoral neck–fracture patients receiving total hip arthroplasty (THA). Patients and Methods In total, 182 computed tomography image pairs from 85 patients were collected and divided into a training set (n=127) and testing set (n=55). Least absolute shrinkage–selection operator regression was used for selecting optimal predictors. A random-forest algorithm was used to establish the prediction models, which were evaluated for accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC). Results The best model in this study was constructed based on demographic data, preoperative laboratory indicators, and three preoperative radiomic features. In the random-forest model, activated partial thromboplastin time, a preoperative radiomic feature (maximum diameter), and fibrinogen were important variables correlating with patient outcomes. The AUC, sensitivity, specificity, PPV, NPV, and accuracy in the training set were 0.986 (95% CI 0.971–1), 0.925 (95% CI 0.862–0.988), 0.983 (95% CI 0.951–1.016), 0.984 (95% CI 0.953–1.014), 0.922 (95% CI 0.856–0.988), and 0.953 (95% CI 0.916–0.990), respectively. The AUC, sensitivity, specificity, PPV, NPV, and accuracy in the testing set were 0.949 (95% CI 0.885–1), 0.767 (95% CI 0.615–0.918), 1 (95% CI 1–1), 1 (95% CI 1–1), 0.781 (95% CI 0.638–0.924), and 0.873 (95% CI 0.785–0.961), respectively. Conclusion The model based on demographic, preoperative clinical, and preoperative radiomic data showed the best predictive ability for 6-month prognosis in the femoral neck–fracture patients receiving THA.

show abstract

Measures of Hip Function and Symptoms

Cited by 10 publications

References 147 publications

Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia

Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia

The AktiWeb study: feasibility of a web-based exercise program delivered by a patient organisation to patients with hip and/or knee osteoarthritis

Prediction Models for Prognosis of Femoral Neck–Fracture Patients 6 Months after Total Hip Arthroplasty

Contact Info

Product

Resources

About